Jingwen Zhu

Dr. Jingwen Zhu

orcid

Research Focus & Metrics

Academic Career Length

4Years (2023-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
23 October 2025 in Cancers
Verified
Journal Article
Open access
PDF file
JLJianjian Lin
Jianjian Lin
JZJingwen Zhu
Jingwen Zhu
JFJay H. Fowke
Jay H. Fowke
Ramesh NarayananRamesh Narayanan
Ramesh Narayanan
FLFeng Liu-Smith
Feng Liu-Smith
Several major cancer types exhibit significant sex dimorphism in incidence and survival. Whether and how sex as a biological factor impacts tumorigenesis, progression, and survival warrants full investigation, as such knowledge may lead to novel, precise prevention and treatment strategies. We reviewed epidemiological and molecular data on sex differences in cancers of the esophagus, bladder, head and neck, lung, liver, kidney, stomach, and skin melanoma, as well as the potential role of androgens and androgen receptor (AR) activity in these cancers. The potential molecular mechanisms are briefly discussed. Elevated testosterone (T) levels seemed to be associated with increased liver cancer and cutaneous melanoma incidences, and with reduced esophageal cancer risk. AR activity does not always correlate with T levels in tumorigenesis and progression. Higher AR expressions are associated with poorer survival in ESCC, whereas the role of AR in the survival of HNSCC and melanoma patients is inconsistent. The molecular impact of AR in liver cancer, kidney cancer, melanoma, and lung cancer is controversial. However, AR is likely to promote tumor growth and/or progression in esophagus, bladder, head and neck, and stomach cancers, and thus is associated with poor survival. Patients diagnosed with a tumor in this latter group could potentially benefit from therapeutic approaches targeting AR. Overall, the research on sex hormone androgens and AR in these cancers is limited. Further research is needed to determine a possible U-shaped relationship of T with cancer risk, and to decipher the role of testosterone and AR in some of these tumors to facilitate our understanding of sex dimorphism and to explore novel T/AR-based treatment options.

3 December 2025 in Nature Communications
Verified
Journal Article
Open access
PDF file
JZJingwen Zhu
Jingwen Zhu
SRSabina Ranjit
Sabina Ranjit
TGTomoka Gose
Tomoka Gose
ANAmanda Nourse
Amanda Nourse
VPVishwajeeth R. Pagala
Vishwajeeth R. Pagala
JSJohn Schuetz
John Schuetz
Cyclic AMP (cAMP) compartmentalization at the plasma membrane employs export by ABCC4, yet the protein machinery that creates spatially restricted signaling has remained unclear. We show that robust PKA activation increases ABCC4 at the cell surface and assembles a PDZ-dependent macromolecular complex that constrains ABCC4 mobility and stabilizes the transporter. Using Avi-tag crosslinking/AP-MS and APEX proximity labeling, we map a PKA-induced ABCC4 neighborhood enriched for PDZ-domain scaffolds that couple ABCC4 to actin and cell junctions. SCRIB emerges as a previously unrecognized interactor whose depletion lowers surface ABCC4 and blunts ABCC4-dependent drug resistance. Deleting the ABCC4 PDZ motif accelerates lateral diffusion ~4-fold, halves protein half-life, and attenuates PKA-stimulated increases in surface ABCC4 and cAMP efflux, establishing a requirement for the PDZ motif in optimal export under PKA drive. Finally, the selective ABCC4 inhibitor Ceefourin-2 lowers ABCC4’s melting temperature and dismantles the actin/junction–enriched neighborhood, revealing a non-classical small molecule inhibitory mechanism based on network disruption. These findings define a PKA-driven, PDZ-dependent ABCC4 protein neighborhood that stabilizes the transporter and optimizes cAMP efflux—an advance over prior work that localized ABCC4 but lacked a mechanistic blueprint for its membrane microdomain organization.

9 June 2025
Verified
Thesis
Closed access
PDF file
JZJingwen Zhu
Jingwen Zhu
Our current knowledge of regulators in vertebrates’ Hedgehog (HH) pathway is incomplete. Gaining a better understanding of HH pathway components is appealing due to the key role of the Sonic Hedgehog (SHH) pathway in modulating the developmental proliferation of granule neuron progenitors (GNPs) in the cerebellum. Aberrant activation of SHH pathway in GNPs promotes the formation of SHH-Medulloblastoma (SHH-MB), a common pediatric brain tumor. Though SHH-MB is genetically understood, current therapies are ineffective. Recently, we identified a scaffold protein, Scribble (Scrib), as a novel interactor of our previously identified SHH pathway regulator—Abcc4. Scrib’s reported expression in the brain also suggested that Scrib had a potential connection to the SHH pathway. However, so far it is unknown whether Scrib regulates the SHH pathway. In this study, I first provided evidence that Scrib is expressed in the developing cerebellum most prominently when the HH pathway is most active. Scrib's enrichment in proliferating GNPs and purified SHH-MB tumor cells led to my hypothesis that Scrib contributes to SHH pathway activation. This hypothesis was further supported by both in vitro and in vivo studies using preclinical SHH-MB models. These studies showed that suppression of Scrib diminished the intensity of the SHH pathway and reduced tumor growth. I then used the NIH-3T3 cell line, a model system that robustly responds to SHH ligand, to elucidate Scrib's role in the SHH pathway regulation. Surprisingly, in an Abcc4-independent fashion, Scrib potently modulated the SHH pathway by affecting SHH-induced amount of nuclear Gli2, a transcription factor which is a downstream activator of the SHH pathway cascade. Next, to determine why nuclear Gli2 expression is affected, a phospho-proteomic study was conducted. This study found that Scrib influences the phosphorylation at multiple Gli2 sites. Follow-up investigations, including site-directed mutagenesis and subcellular fractionation, showed that phosphorylation of S232 is critical to both optimal Gli2 activity and nuclear Gli2 expression. These findings narrowed down the Scrib effect to Gli2 phosphorylation at a single residue —S232. In addition, I extended these studies to identify the kinase mediating the phosphorylation of Gli2 at S232. Among the candidate kinases screened, CK1ε was the most likely kinase that phosphorylates Gli2-S232.

18 May 2023 in The Journal of Pharmacology and Experimental Therapeutics
Verified
Journal Article
Open access
PDF file
JZJingwen Zhu
Jingwen Zhu
SRSabina Ranjit
Sabina Ranjit
Yao WangYao Wang
Yao Wang
FZFrederique Zindy
Frederique Zindy
MRMartine Roussel
Martine Roussel
JSJohn Schuetz
John Schuetz
ID 28302 Poster Board 39 Sonic Hedgehog (SHH) signaling plays a crucial role in cerebellum development by controlling the proliferation of granule neuron progenitors (GNP). Its aberrant expression results in SHH-Medulloblastoma (MB), which is among the most prevalent pediatric brain tumors in children younger than 3 years old. Though SHH-MB is genetically understood, current therapies are ineffective. There is an unmet need to identify new targetable regulators of SHH signaling to improve outcomes. We previously reported that the ABC transporter ABCC4 was expressed in MB and modulated the intensity of SHH pathway activity1, and have recently identified Scribble (SCRIB) as a protein that binds to the PDZ motif of ABCC4. SCRIB is a conserved scaffold protein that has known roles in cell polarity and coordinates several signaling pathways2. A recent study discussed SCRIB’s association with neurodevelopmental disorders3. However, it is unknown whether SCRIB regulates the SHH pathway. In mouse cerebellum, we found that Scrib is highly expressed at postnatal day 1-7 (when SHH signaling is most active) and specifically expressed in proliferating GNPs. We hypothesized that SCRIB might regulate SHH signaling by either affecting ABCC4 or acting independently. To test if SCRIB is required for SHH signaling, Scrib knockdown by siRNAs was performed in NIH-3T3 cells, a model of the SHH pathway. SHH signaling was initiated by either SHH ligand or Smoothened (Smo) agonist SAG. The activation was assessed by Gli1 expression, a target gene of SHH signaling. Our results showed that suppression of Scrib remarkably diminished both mRNA (p<0.05) and protein level (p<0.01) of Gli1, demonstrating that SCRIB is a positive regulator of SHH signaling. We then used CRISPR-Cas9 to develop NIH-3T3 Scrib knockout (KO) clones that affirmed Scrib absence impaired SHH signaling. Because ABCC4 regulates SHH signaling by affecting cAMP transport, we excluded the possibility that SCRIB modulates the pathway by affecting ABCC4’s expression, localization and function. We then investigated alternative molecular mechanisms by which SCRIB acts independently of ABCC4. The expression and localization of key elements in SHH signaling were evaluated in ScribKO clones, including Smo and Gli2. There was minimal effect on the upstream SHH activator Smo, but subcellular fractionation revealed that Scrib’s absence dramatically reduced the SHH-induced nuclear expression of Gli2 (p<0.0001), a dominant downstream activator. Cycloheximide turnover studies suggested that SCRIB is required for the stability of GLI2 during SHH signaling. To understand the influence of SCRIB on the aberrant SHH signaling that drives some SHH-MBs, Scrib siRNAs were applied to mouse fibroblast cell lines lacking either Ptch1 or Sufu. Loss of Scrib restrained the constitutive SHH pathway activation produced by Ptch1 or Sufu absence as shown by the dramatic reduction in Gli1(p<0.01). Moreover, SCRIB knockdown in human SHH-MB cell lines, DAOY and UW228, significantly decreased the proliferation of these tumor cells (p<0.02), highlighting that SCRIB suppression is a viable strategy to reduce SHH-MB tumor growth. Overall, our data demonstrates that SCIRB is a new potent modulator of SHH signaling with the potential as a novel target in SHH-MB therapy. This work is supported by NIH and ALSAC. Ref: 1. Wijaya, J. et al.Cancer Res.2020 2. Pires, H. R. & Boxem, M. J. Mol. Biol.2018 3. Ezan, J. et al.Sci. Rep.2021.